Summary
Alpha-lipoic acid, a naturally occuring disulfide-compound that acts as a cellular coenzyme, inhibits replication of HIV-1 in cultured lymphoid T-cells. Alpha-lipoic acid was added 16 hours after infection of the T-cell lines Jurkat, SupT1 and Molt-4 with HTLV IIIB and HIV-1 Wai (a wild type HIV-1 isolate). We observed a dose dependent inhibition of HIV-1-replication in CPE (Cytopathic effect) formation, reverse transcriptase activity and plaque formation on CD4-transformed HeLa-cells. An over 90% reduction of reverse transcriptase activity could be achieved with 70 μg alpha-lipoic acid/ml, a complete reduction of plaque-forming units at concentrations of ≥35 μg alpha-lipoic acid/ml. An augmentation of the antiviral activity was seen by combination of zidovudine and low dose of alpha-lipoic acid (7 μg/ ml). Trypan blue staining revealed no toxic effects of alpha-lipoic acids on peripheral blood mononuclear cells and T-cell lines even in concentrations of ≥70 μg/ml. Therefore, we propose the inclusion of alpha-lipoic acid into chemotherapy trials in combination with zidovudine.
Similar content being viewed by others
Abbreviations
- HIV:
-
Human immunodeficiency virus
- HTLV:
-
Human T-lymphotropic virus
- MOI:
-
multiplicity of infection
- AZT:
-
Azidothymidine (zidovudine)
- PBMC:
-
peripheral blood mononuclear cells
- PHA:
-
Phythämagglutinin
- CPE:
-
cytopathic effect
- RT:
-
reverse transcriptase
- CD:
-
Cluster of differentiation
- cpm:
-
counts per minute
References
Chandra A, Demirhan I, Arya SK, Chandra P (1988) D-Penicillamin inhibits transactivation of human immunodeficiency virus type-1 (HIV-1) LTR by transactivator protein. FEBS Lett 236:282–286
Chesebro B, Wehrly K (1988) Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity. J Virol 62:3779–3788
Gregersen JP, Wege H, Preiss L, Jentsch KD (1988) Detection of human immunodeficiency virus and other retroviruses in cell culture supernatants by a reverse transcriptase microassay. J Virol Meth 19:161–168
Harrison EH, McCormick DB (1974) Metabolism of d,1-lipoic-1,6-carbon-14-labeled acid in the rat. Arch Biochem Biophys 160:514–522
Kubota SK, El-Farrash MA, Maki M, Harada S, Hatanaka M (1990) 2,3 Dimercapto-1-Propanol inhibits HIV-1 tat activity, viral production, and infectivity in vitro. AIDS Res Human Retroviruses 6:919–927
Ohmori H, Yamauchi T, Zamamoto I (1986) Augmentation of the antibody response by lipoic acid in mice. I. Analysis of the mode of action in an in vitro cultures system. Jpn J Pharmacol 42:135–140
Ohmori H, Yamauchi T, Zamamoto I (1986) Augmentation of the antibody response by lipoic acid in mice. II. Restoration of the antibody response in immunosuppressed mice. Jpn J Pharmacol 42:275–280
Roederer M, Staal FJT, Raju PA, Ela SW, Herzenberg LA, Herzenberg LA (1990) Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine. Proc Natl Acad Sci USA 87:4884–4888
Sachse G, Willms B (1980) Efficacy of thioctic acid in the therapy of peripheral diabetic neuropathy. Ref Internat Symp of the German association “Aspects of autonomic neuropathy in diabetes”. Hormone Metabol Res 9:105–108
Author information
Authors and Affiliations
Additional information
We thank Susanne Gack, Maria Neundörfer and Ute Ehrmann for expert technical assistance.
Rights and permissions
About this article
Cite this article
Baur, A., Harrer, T., Peukert, M. et al. Alpha-lipoic acid is an effective inhibitor of human immuno-deficiency virus (HIV-1) replication. Klin Wochenschr 69, 722–724 (1991). https://doi.org/10.1007/BF01649442
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01649442